What hemolytic anemia is and why it happens

Hemolytic anemia occurs when your red blood cells are destroyed faster than your body can replace them. In normal circumstances, red blood cells live about 120 days before your spleen removes them and your bone marrow makes new ones. In hemolytic anemia, that lifespan shortens to days or even hours, so your body cannot keep up with the loss.

The destruction can happen for several reasons. Your immune system may mistakenly attack your own red blood cells, treating them as foreign invaders. Alternatively, physical damage—from a mechanical heart valve, severe burns, or tiny blood clots in small vessels—can rupture cells as they circulate. Some people inherit conditions like sickle cell disease or hereditary spherocytosis that make their red blood cells fragile and prone to breaking apart. Infections, certain medications, or toxins can also trigger the breakdown.

What matters clinically is that hemolysis (the destruction of red blood cells) outpaces production. Your bone marrow tries to compensate by making more cells faster, but eventually falls behind. The result is fewer healthy red blood cells carrying oxygen, which is what defines anemia.

Key Takeaways

  • Hemolytic anemia means red blood cells are being destroyed faster than your body can make new ones, whether from immune attack, physical damage, inherited conditions, or infections.
  • Symptoms include fatigue, shortness of breath, jaundice (yellowing of skin and eyes), dark urine, and sometimes pain in the upper left side of the abdomen where the spleen is located.
  • Diagnosis involves blood tests that show low hemoglobin, high reticulocyte count (immature red cells), elevated bilirubin, and sometimes a positive Coombs test that detects immune attack on red cells.
  • Treatment depends on the cause: immune-mediated hemolysis may respond to corticosteroids or immunosuppressants, while inherited forms may require transfusions, folic acid, or in severe cases, surgery to remove the spleen.

How your body signals hemolytic anemia

The symptoms of hemolytic anemia overlap with other forms of anemia but often develop more rapidly because the cell destruction is acute. You may notice fatigue and weakness that worsens over days or weeks, along with shortness of breath during normal activity. Dizziness, headaches, and pale or yellowish skin are common.

A distinctive sign is jaundice—yellowing of the skin and the whites of the eyes. This happens because when red blood cells break down, they release hemoglobin, which your liver converts to bilirubin. When hemolysis is severe, bilirubin accumulates faster than your liver can process it, causing the yellow discoloration. Your urine may also darken, turning tea-colored or cola-colored, because bilirubin is being filtered into it.

Some people experience pain or fullness in the upper left abdomen, where the spleen sits. The spleen works overtime during hemolytic anemia, filtering destroyed cells and trying to clear the debris, which can cause it to enlarge and become tender. Fever, chills, and back pain can occur if an infection is driving the hemolysis.

How doctors identify hemolytic anemia

Diagnosis begins with a complete blood count (CBC), which measures hemoglobin and hematocrit levels. In hemolytic anemia, these are low, but the pattern of other results points toward hemolysis rather than simple blood loss or bone marrow failure. The reticulocyte count—a measure of immature red blood cells—is typically elevated because your bone marrow is working hard to replace destroyed cells.

A blood smear examined under a microscope may show fragmented or abnormally shaped red cells, depending on the cause. Your doctor will also order tests for bilirubin and lactate dehydrogenase (LDH), both of which rise when red cells break down. Haptoglobin, a protein that binds to hemoglobin released from destroyed cells, typically drops during active hemolysis.

The Coombs test (also called the direct antiglobulin test) is often crucial. It detects antibodies or complement proteins stuck to the surface of your red blood cells, indicating immune-mediated hemolysis. A positive Coombs test points toward autoimmune hemolytic anemia, while a negative result suggests a different cause—inherited fragility, mechanical damage, or infection.

If hemolysis is confirmed, your doctor may order additional tests depending on the suspected cause: a peripheral blood smear to look for sickle cells or spherocytes, genetic testing for inherited conditions, or imaging to check for an enlarged spleen or other abnormalities.

Immune-mediated hemolytic anemia and how it is treated

Autoimmune hemolytic anemia (AIHA) is the most common form in adults. Your immune system produces antibodies against your own red blood cells, marking them for destruction. This can happen on its own (primary AIHA) or as a complication of another condition like lupus, lymphoma, or chronic lymphocytic leukemia (secondary AIHA).

Treatment typically starts with corticosteroids, usually prednisone, which suppress the immune response and reduce antibody production. Many patients improve within days to weeks, though some require months of treatment. If steroids alone do not work or cause unacceptable side effects, doctors may add immunosuppressive medications like azathioprine, mycophenolate, or rituximab (a monoclonal antibody that targets B cells that produce the destructive antibodies).

In severe cases where the hemolysis is life-threatening and medications are not working fast enough, blood transfusions may be necessary. This is tricky because the patient's antibodies may attack the transfused cells too, but transfusion can be a bridge while other treatments take effect. If medications fail over time, removal of the spleen (splenectomy) is sometimes considered, since the spleen is the main site where antibody-coated red cells are destroyed.

Inherited hemolytic anemias and their management

Some people are born with red blood cells that are inherently fragile. Hereditary spherocytosis is one example: the red cells are shaped like spheres rather than the normal biconcave discs, making them more prone to rupturing. Sickle cell disease is another: hemoglobin molecules polymerize under low oxygen, distorting the cell into a sickle shape that gets stuck in small blood vessels and breaks apart.

Treatment for inherited hemolytic anemias focuses on managing symptoms and preventing complications. Folic acid supplementation is standard because the bone marrow's increased production of red cells depletes folate stores. Pain management, hydration, and oxygen therapy are used during acute episodes. Some patients with hereditary spherocytosis benefit from splenectomy, which removes the main site of cell destruction and can significantly reduce hemolysis.

For sickle cell disease, treatment has expanded beyond transfusions and pain relief. Hydroxyurea increases fetal hemoglobin production, which does not polymerize and reduces sickling. Newer medications like voxelotor (which increases hemoglobin's oxygen affinity) and L-glutamine (which reduces oxidative stress) have shown benefit. Gene therapy and bone marrow transplantation are emerging options for may be able to access patients.

Other causes and when to seek evaluation

Hemolytic anemia can also result from infections—malaria, babesiosis, and certain bacterial infections directly damage red cells or trigger immune destruction. Medications like penicillin, sulfonamides, and some antimalarials can cause drug-induced hemolytic anemia. Severe burns, artificial heart valves, or disseminated intravascular coagulation (a serious clotting disorder) cause mechanical fragmentation of cells.

Microangiopathic hemolytic anemia occurs when tiny blood clots or abnormal vessel narrowing shreds red cells as they pass through. This can happen in conditions like thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), or severe hypertension.

You should seek medical evaluation if you develop unexplained fatigue, shortness of breath, jaundice, or dark urine—especially if these symptoms appear suddenly or worsen over days. If you have a known condition that increases hemolysis risk (like sickle cell disease or lupus) and your symptoms change, contact your doctor promptly. Severe hemolytic anemia can lead to heart failure, kidney damage, or life-threatening complications, so early diagnosis and treatment matter.

Living with hemolytic anemia long-term

For people with chronic hemolytic anemia, ongoing monitoring is essential. Regular blood tests track hemoglobin, reticulocyte count, and bilirubin to catch worsening hemolysis early. If you are on immunosuppressive medications, your doctor will monitor for infections and other side effects. Bone density screening may be needed if you are on long-term corticosteroids.

Lifestyle measures support treatment. Staying well-hydrated helps your kidneys handle the bilirubin load. Avoiding triggers—for sickle cell patients, this means preventing dehydration, infection, and extreme temperature exposure; for others, it means identifying and avoiding medications or foods that worsen hemolysis. Folic acid supplementation is often lifelong because your bone marrow continues working harder than normal.

Genetic counseling is important if you have an inherited form of hemolytic anemia and are considering having children. Many inherited hemolytic anemias follow predictable inheritance patterns, and knowing your risk can inform family planning decisions.

Frequently Asked Questions

Is hemolytic anemia the same as regular anemia?

No. Regular anemia usually results from blood loss, iron deficiency, or bone marrow failure to make enough cells. Hemolytic anemia is specifically about red cells being destroyed too fast. The distinction matters because treatment is different—iron supplements will not help if your cells are being destroyed, and immunosuppressants will not help if you simply lack iron.

Can hemolytic anemia go away on its own?

Some cases do resolve without treatment, particularly if hemolysis is triggered by a temporary infection or medication that is then stopped. Autoimmune hemolytic anemia sometimes enters remission spontaneously. However, inherited forms like sickle cell disease and hereditary spherocytosis are lifelong conditions. Your doctor will determine whether your case requires treatment or can be monitored.

What happens if hemolytic anemia is not treated?

Untreated hemolytic anemia can worsen, leading to severe fatigue, heart failure from the heart working harder to pump oxygen-poor blood, kidney damage from bilirubin accumulation, and gallstones from excess bilirubin. In acute severe hemolysis, the sudden drop in red blood cells can be life-threatening. Treatment prevents these complications.

Can I donate blood if I have hemolytic anemia?

No. Blood banks will not accept donations from people with active hemolytic anemia because your hemoglobin is already low and donation would worsen your condition. If your hemolytic anemia is well-controlled and your hemoglobin is in a safe range, ask your doctor whether donation is safe in your specific situation.

Does hemolytic anemia run in families?

Inherited forms like sickle cell disease, hereditary spherocytosis, and G6PD deficiency do run in families and follow genetic inheritance patterns. Autoimmune hemolytic anemia is not directly inherited but may cluster in families with autoimmune conditions. If hemolytic anemia runs in your family, genetic counseling can clarify your risk.